Rchr
J-GLOBAL ID:200901009856766468   Update date: Jan. 31, 2024

Shirai Atsuko

シライ アツコ | Shirai Atsuko
Affiliation and department:
Job title: 研究員
Research field  (1): Cell biology
Research theme for competitive and other funds  (3):
  • 2018 - 2021 Ectopic assembly of mammalian heterochromatin triggered by tandem repetitive DNA
  • 2011 - 2013 DNA損傷時のユビキチン修飾による高次クロマチン構造の動的制御
  • 2011 - 2013 Analysis of ubiquitin modification regulating heterochromatin structure
Papers (13):
  • Shabeesh Balan, Yoshimi Iwayama, Tetsuo Ohnishi, Mikiko Fukuda, Atsuko Shirai, Ayumi Yamada, Sara Weirich, Maren Kirstin Schuhmacher, Kalarickal Vijayan Dileep, Toshihiro Endo, et al. A loss-of-function variant in SUV39H2 identified in autism-spectrum disorder causes altered H3K9 trimethylation and dysregulation of protocadherin β-cluster genes in the developing brain. Molecular psychiatry. 2021
  • Eriko Oya, Reiko Nakagawa, Yuriko Yoshimura, Mayo Tanaka, Gohei Nishibuchi, Shinichi Machida, Atsuko Shirai, Karl Ekwall, Hitoshi Kurumizaka, Hideaki Tagami, et al. H3K14 ubiquitylation promotes H3K9 methylation for heterochromatin assembly. EMBO reports. 2019. 20. 10. e48111
  • Akihisa Matsuyama, Atsuko Shirai, Minoru Yoshida. Preparation of cell lysates of fission yeast for immunoprecipitation. Methods in Molecular Biology. 2018. 1721. 125-133
  • Shirai A, Kawaguchi T, Shimojo H, Muramatsu D, Ishida-Yonetani M, Nishimura Y, Kimura H, Nakayama JI, Shinkai Y. Correction: Impact of nucleic acid and methylated H3K9 binding activities of Suv39h1 on its heterochromatin assembly. eLife. 2017. 6
  • Atsuko Shirai, Takayuki Kawaguchi, Hideaki Shimojo, Daisuke Muramatsu, Mayumi Ishida-Yonetani, Yoshifumi Nishimura, Hiroshi Kimura, Jun-ichi Nakayama, Yoichi Shinkai. Impact of nucleic acid and methylated H3K9 binding activities of Suv39h1 on its heterochromatin assembly. ELIFE. 2017. 6
more...
MISC (4):
Professional career (1):
  • 農学博士 (東京大学大学院)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page